Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan

Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease

Tohru Kobayashi, Yoshinari Inoue, Kazuo Takeuchi et al. · Circulation · 2006 · 911 citations

Life Sciences, Immunology, Pharmacotherapy +14

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

Bernard J. Scallon · Cytokine · 1995 · 682 citations

Life Sciences, Immunology, Molecular Biology +12

Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)

Tohru Kobayashi, Mamoru Ayusawa, Hiroyuki Suzuki et al. · Pediatrics International · 2020 · 597 citations

Public Health, Infectious Diseases, Clinical Epidemiology +5

Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)

Mamoru Ayusawa, Tomoyoshi Sonobe, Shigeru Uemura et al. · Pediatrics International · 2005 · 492 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +5

Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

Tsutomu Takeuchi, Yoshihiko Tatsuki, Yashiro Nogami et al. · Annals of the Rheumatic Diseases · 2007 · 413 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17